Kai Zhao

发表

A machine learning approach to drug repositioning based on drug expression profiles: Applications to schizophrenia and depression/anxiety disorders

H. So, Kai Zhao, 2017 .

Translating GWAS findings into therapies for depression and anxiety disorders: gene-set analyses reveal enrichment of psychiatric drug classes and implications for drug repositioning

H. So, C. K. Chau, Kai Zhao, 2018, Psychological Medicine.

Exploring repositioning opportunities and side-effects of statins: a Mendelian randomization study of HMG-CoA reductase inhibition with 55 complex traits

C. K. Chau, Kai Zhao, SO Hon-Cheong, 2017, bioRxiv.

INSIDER: Interpretable Sparse Matrix Decomposition for Bulk RNA Expression Data Analysis

P. Sham, H. So, Zhixiang Lin, 2022, bioRxiv.

Prediction of Drug Targets for Specific Diseases Leveraging Gene Perturbation Data: A Machine Learning Approach

H. So, Kai Zhao, Yujia Shi, 2021, bioRxiv.

Drug Repositioning for Schizophrenia and Depression/Anxiety Disorders: A Machine Learning Approach Leveraging Expression Data

Kai Zhao, Hon-Cheong So, H. So, 2019, IEEE Journal of Biomedical and Health Informatics.

Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.

Kai Zhao, Hon-Cheong So, H. So, 2018, Methods in molecular biology.

A machine learning approach to drug repositioning based on drug expression profiles: Applications in psychiatry

Hon-Cheong So, Kai Zhao, H. So, 2017, 1706.03014.

Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer

Mousheng Xu, Kwok-Kin Wong, J. Qi, 2020, Cancer Research.

Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.

H. So, Kai Zhao, 2018, Methods in molecular biology.

SR2: Sparse Representation Learning for Scalable Single-cell RNA Sequencing Data Analysis

H. So, Zhixiang Lin, Kai Zhao, 2023, bioRxiv.